首页> 外文期刊>National Journal of Medical Research >Is There Any Role Of Induction Chemotherapy In Unresectable Locally Advanced Head And Neck Cancers: An Institutional Data.
【24h】

Is There Any Role Of Induction Chemotherapy In Unresectable Locally Advanced Head And Neck Cancers: An Institutional Data.

机译:在无法切除的局部晚期头颈癌中,诱导化疗是否有任何作用:一项机构数据。

获取原文
       

摘要

Background: Head and neck cancers are very common in India due to habit of betel quid and areca nut chewing along with bidi smoking and alcoholism, with more than half of the patients presenting in locally advanced stage. Chemo-radiotherapy with or without induction chemotherapy is the mainstay of treatment for these patients. We have performed a prospective study to determine the effectiveness of induction chemotherapy followed by concurrent chemo-radiotherapy. Methodology: A total of 20 patients with unresectable locally advanced head and neck cancers were enrolled in the study. Treatment included two cycles of induction chemotherapy with Paclitaxel (135mg/m2, day1) and Cisplatin (40mg/m2 onday1, 2) at an interval of 21days followed by Cisplatin 40mg/m2 weekly along with conventional radiotherapy (70Gy/35#/7weeks). The tumor response and acute toxicities were evaluated. Results: Of the 20 patients, only 8 patients completed the planned treatment schedule. Of the 8 patients, radiological complete response was observed in 5 patients. The partial response was seen in 2 patients. One patient had progressive disease. Few grade 1 and 2 toxicities including skin toxicity, diarrhea, anemia, acute kidney injuryand peripheral sensory neuropathy were observed. Only 4 patients had grade 3 toxicities of acute mucositis, vomiting and neutropenia. Conclusion: Sequential therapy incorporating induction chemotherapy and chemo-radiotherapy appears to be an inferior approach. Further investigations are required to select a better regimen in patients with unresectable locally advanced head and neck cancer.
机译:背景:由于槟榔和槟榔的咀嚼以及比迪烟和酒精中毒的习惯,头颈癌在印度非常普遍,超过一半的患者处于局部晚期。接受或不接受诱导化疗的化学放射疗法是这些患者的主要治疗手段。我们进行了一项前瞻性研究,以确定诱导化疗后同步放化疗的有效性。方法:共有20例无法切除的局部晚期头颈癌患者参加了研究。治疗包括以紫杉醇(135mg / m2,第1天)和顺铂(第1天,第2天,40mg / m2)的两个诱导化疗周期,间隔21天,然后每周一次顺铂40mg / m2加上常规放疗(70Gy / 35#/ 7周) 。评价肿瘤反应和急性毒性。结果:在20名患者中,只有8名患者完成了计划的治疗计划。在8例患者中,有5例观察到放射学完全缓解。在2例患者中观察到部分反应。一名患者患有进行性疾病。几乎没有观察到1级和2级毒性,包括皮肤毒性,腹泻,贫血,急性肾损伤和周围感觉神经病。仅4例患者具有急性粘膜炎,呕吐和中性粒细胞减少的3级毒性。结论:序贯疗法结合诱导化学疗法和化学放射疗法似乎是一种较差的方法。对于无法切除的局部晚期头颈癌患者,需要进一步研究以选择更好的治疗方案。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号